Skip to main content
Adamis' generic EpiPen wins FDA nod

Adamis Pharmaceuticals received FDA approval for its Symjepi, or epinephrine prefilled syringe, a generic version of EpiPen intended for treatment of allergic reactions including anaphylaxis. The company is planning to file a second new-drug application for a junior version of Symjepi with the agency.

Full Story: